Published in Biochem Biophys Res Commun on October 08, 2011
Prognostic Value of Cancer Stem Cell Marker ALDH1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis. PLoS One (2015) 0.88
Activation of the Wnt pathway through AR79, a GSK3β inhibitor, promotes prostate cancer growth in soft tissue and bone. Mol Cancer Res (2013) 0.87
Loss of expression of the cancer stem cell marker aldehyde dehydrogenase 1 correlates with advanced-stage colorectal cancer. Am J Surg (2012) 0.87
Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis. Br J Cancer (2014) 0.87
Prostate cancer and parasitism of the bone hematopoietic stem cell niche. Crit Rev Eukaryot Gene Expr (2012) 0.84
Prostate cancer stem cell biology. Minerva Urol Nefrol (2012) 0.81
Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression. Oncotarget (2015) 0.81
H460 non-small cell lung cancer stem-like holoclones yield tumors with increased vascularity. Cancer Lett (2013) 0.78
Enhanced contactless dielectrophoresis enrichment and isolation platform via cell-scale microstructures. Biomicrofluidics (2016) 0.77
Clonogenicity: holoclones and meroclones contain stem cells. PLoS One (2014) 0.77
ΔNp63α promotes adhesion of metastatic prostate cancer cells to the bone through regulation of CD82. Oncogene (2017) 0.75
EZH2 promotes proliferation and invasiveness of prostate cancer cells. Prostate (2007) 1.34
Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis. Breast Cancer Res Treat (2004) 1.25
A critical appraisal of the prognostic and predictive factors for uveal malignant melanoma. Histopathology (2004) 1.14
Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells. Cancer Res (2000) 1.01
Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation. Br J Ophthalmol (2001) 0.95
Two cases of double melanoma of the uvea. Eye (Lond) (1996) 0.91
Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma. Eye (Lond) (2006) 0.88
A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins. Br J Ophthalmol (2001) 0.86
Areal and laminar distribution of neurons interconnecting the central visual cortical areas 17, 18, 19, and MT in squirrel monkey (Saimiri). J Comp Neurol (1981) 0.85
Expression of integrins, degradative enzymes and their inhibitors in uveal melanoma: differences between in vitro and in vivo expression. Melanoma Res (2001) 0.84
Subcortical structures projecting to visual cortical areas in squirrel monkey. J Comp Neurol (1982) 0.84
Reduced expression of TAP-1 and TAP-2 in posterior uveal melanoma is associated with progression to metastatic disease. Melanoma Res (2001) 0.83
Cytokine modulation of antigen expression in human melanoma cell lines derived from primary and metastatic tumour tissues. Melanoma Res (1997) 0.83
Invasive and noninvasive uveal melanomas have different adhesive properties. Eye (Lond) (2005) 0.81
Reduced FANCD2 influences spontaneous SCE and RAD51 foci formation in uveal melanoma and Fanconi anaemia. Oncogene (2013) 0.81
Alpha-melanocyte stimulating hormone can reduce T-cell interaction with melanoma cells in vitro. Melanoma Res (2000) 0.79
Resistance of uveal melanoma to the interstrand cross-linking agent mitomycin C is associated with reduced expression of CYP450R. Br J Cancer (2011) 0.77
The in vivo modulatory effects of an anterior-chamber microenvironment on uveal melanoma. Br J Ophthalmol (2008) 0.77
Cytogenetic analysis in ocular lymphoma. Br J Ophthalmol (2001) 0.75
What is the significance of vortex vein invasion in uveal melanoma? Eye (Lond) (2008) 0.75
CD80-mediated induction of immunostimulation in two ocular melanoma cell lines is augmented by interferon-gamma. Melanoma Res (2002) 0.75